OpGen > Company > News

News

Welcome to the OpGen News page, home to the most recent information about new OpGen developments, products and services. For background on OpGen, please see also our Company Overview  and Investor Relations pages; for the latest company updates, read our most recent press releases and announcements, below.

Media Inquiries

Michael Farmer, Director Marketing
OpGen, Inc.
mfarmer@OpGen.com
P  240.813.1284

Investor Inquiries

Eric Winzer, CFO
OpGen, Inc.
InvestorRelations@OpGen.com
P 240.813.1289

Press Releases and Announcements

All OpGen press releases are issued in the United States. Press releases reflect current information at the time of issuance and therefore may not reflect present developments.

10/16/2013 

OpGen and Hitachi High-Technologies Corporation Enter into an Agreement to Develop Human Chromosome Mapping Service

07/23/2013

OpGen Opens CLIA Certified Clinical Services Laboratory and  Launches Microbial Genetic Tests for Healthcare Associated Infections

06/3/2013

OpGen Announces Partnership with Applied Maths to Provide Bioinformatics Analysis Software for Whole Genome Mapping

05/16/2013

OpGen to Present New Data on the Application of Whole Genome Mapping in Microbial Outbreaks at the American Society for Microbiology 113th General Meeting

12/26/2012

OpGen Announces Sequence Assembly and Finishing of First Reference Genome of Domestic Goat

12/19/2012

OpGen Announces Partnership with University of California, Davis, to Develop High Resolution Microbial Genetic Maps in Support of The 100K Genome Project

11/19/2012

OpGen Announces Expanded Adoption of Argus® Whole Genome Mapping System

05/30/2012 Life Technologies and OpGen Sign Collaborative Agreement to Leverage Ion Torrent and Whole Genome Mapping Technologies
05/17/2012 Public Health Consortium to Evaluate Whole Genome Mapping for Improved Genetic Analysis of Disease Outbreaks
05/1/2012 OpGen Announces Strategic Collaboration with IQT to Develop High-Throughput Genomic Assembly and Analysis System
03/7/2012 OpGen Completes Growth Capital Financing
02/23/2012 OpGen Announces Participation in New European Union Clinical Microbiology Research Consortium
02/14/2012 OpGen Demonstrates Whole Human Chromosome Mapping Capabilities at 2012 AGBT Meeting
01/17/2012 OpGen’s Whole Genome Mapping System and Genome-Builder™ Software Suite Featured at the International Plant & Animal Genome XX Conference
12/20/2011 OpGen Strengthens Management Team to Accelerate Commercialization Strategy
10/13/2011 OpGen Announces Launch of Genome-Builder, a Breakthrough Advance for Sequence Assembly and Structure Variation Analysis in Large Genomes
10/11/11 OpGen’s Whole Genome Mapping Technology Provides Critical Genomic Information for Malaria Research
8/18/11 Frost & Sullivan New Product Innovation Award Recognizes OpGen’s Argus® Whole Genome Mapping System
6/13/11 Optical Mapping First to Definitively Determine Deadly E. coli Strains in German Outbreak Are From a Single Source and Related to Earlier Outbreaks
5/23/11 The University of Maryland Institute for Genome Sciences (IGS) and OpGen, Inc Announce Collaboration to Develop Microbial Sequence Database
2/8/11 OpGen Announces Argus® Optical Mapping System Purchase by BGI
1/6/11 OpGen Announces Argus® Optical Mapping System Purchase by Wellcome Trust Sanger Institute
11/30/10 OpGen, Inc., to Present at the Piper Jaffray 22nd Annual Health Care Conference
11/4/10 BGI and OpGen Collaborate on Use of Optical Mapping for Whole Genome Assembly
9/27/10 OpGen Completes $17 Million Series B Financing

Awards

OpGen, Inc. Receives Frost & Sullivan New Product
Innovation Award

OpGen, Inc., a provider of innovative whole genome DNA analysis solutions, announced today the company was chosen to receive the Frost & Sullivan 2011 Best Practice Award for New Product Innovation. The annual Frost & Sullivan awards spotlight “best-in-class” companies based on excellence in managing growth, innovation and leadership, and are selected utilizing Frost & Sullivan’s global research organization of 1,800 analysts and consultants monitoring 300 industries and 250,000 companies. “The New Product Innovation Award recognizes the most innovative, market-changing technologies in the life science community,” notes industry analyst Christi Bird. “We expect OpGen’s Argus® System to become a vital tool in sequencing laboratories to drive efficiency and reduce costs of genome finishing.”

OpGen, Inc. Receives Incubator Company of the Year Award

In recognition of businesses across the county that have shown steadfast commitment to business growth, job creation, workforce training and development, disability hiring, environmental health and personal achievement, OpGen, Inc. was selected as the 2008 Incubator Company of the Year by Montgomery County Maryland’s Department of Economic Development. The award was presented by award-winning FOX5 news anchor Shawn Yancy in the October award ceremony. County Executive Isiah Leggett stated in his closing commentary regarding the award recipients, “…they truly reflect the excellence, diversity and entrepreneurial spirit that exist in Montgomery county’s workforce and business community.”

“Physical map and genetic map still should be emphasized as an important parts of a reference genome. Recent progress in technologies, such as the whole genome mapping high-throughput platform offered by OpGen, now provide the tools for efficient physical map construction. This independent technology provides not only the validation of the genome sequencing, but also provides the large-scale chromosome structure information that cannot be detected by sequencing. We applied this technology as an assistant tool of the NGS to assemble bacterial, plant and large mammalian genome with reliable accuracy and generate the sub-chromosome graded assembly. The experience in these genome assembly projects shows that the physical map should be the standard for any reference genome to be assembled in further.”

Xun Xu, Ph.D.

Deputy Director at BGI
 

This independent technology provides not only the validation of the genome sequencing, but also provides the large-scale chromosome structure information that cannot be detected by sequencing.

Xun Xu, Ph.D.
Deputy Director at BGI

“Our research focuses on a wide variety of projects from viruses and microbes to crop plants and mammals. Many of our projects are de novo assembly projects, where, without a closely related genome sequence, it can be difficult to critically assess the results. We often combine different sequencing technologies, and we are finding that regardless of the sequencing platform, error correction, or assembler used, OpGen’s Whole Genome Mapping identifies misassemblies and provides the highest quality de novo assembly for further research.”

Matthew Clark, Ph.D.

Team Leader, Sequencing Technology Development

The Genome Analysis Centre (TGAC), Norwich, UK

OpGen’s Whole Genome Mapping identifies misassemblies and provides the highest quality de novo assembly for further research.

Matthew Clark, Ph.D.
Team Leader, Sequencing Technology Development

“We adopted OpGen’s Argus System as the most advanced way of adding Whole Genome Mapping to improve whole genome sequences. We combined Whole Genome Maps with sequence assemblies to correct errors and misassemblies in bacterial genome sequences as part of our program in the Human Microbiome Project. We are now moving the technology into larger genome projects.”


George Weinstock, Ph.D.

Associate Director
 The Genome Institute at Washington University

We combined Whole Genome Maps with sequence assemblies to correct errors and misassemblies in bacterial genome sequences. This is part of our program from the Human Microbiome Project.

George Weinstock Ph.D.

Associate Director

The Genome Institute at Washington University

“Certain things you just have a tough time answering with de novo sequencing. And assembly doesn’t always work out as sweetly as you would like. So definitely for any whole genome de novo project that people are insistent on closing we would do a Whole Genome Map optically as well as de novo assembly. And the amount of money you would save is in the thousands of dollars in finishing.”

Stefan Green

Director of DNA Services

University of Illinois Chicago Research Resources Center (UIC RRC)

Definitely for any whole genome de novo project that people are insistent on closing we would do a Whole Genome Map.

Stefan Green
Director of DNA Services

“Physical map and genetic map still should be emphasized as an important parts of a reference genome. Recent progress in technologies, such as the whole genome mapping high-throughput platform offered by OpGen, now provide the tools for efficient physical map construction. This independent technology provides not only the validation of the genome sequencing, but also provides the large-scale chromosome structure information that cannot be detected by sequencing. We applied this technology as an assistant tool of the NGS to assemble bacterial, plant and large mammalian genome with reliable accuracy and generate the sub-chromosome graded assembly. The experience in these genome assembly projects shows that the physical map should be the standard for any reference genome to be assembled in further.”

Xun Xu, Ph.D.

Deputy Director at BGI
 

This independent technology provides not only the validation of the genome sequencing, but also provides the large-scale chromosome structure information that cannot be detected by sequencing.

Xun Xu, Ph.D.
Deputy Director at BGI

“Our research focuses on a wide variety of projects from viruses and microbes to crop plants and mammals. Many of our projects are de novo assembly projects, where, without a closely related genome sequence, it can be difficult to critically assess the results. We often combine different sequencing technologies, and we are finding that regardless of the sequencing platform, error correction, or assembler used, OpGen’s Whole Genome Mapping identifies misassemblies and provides the highest quality de novo assembly for further research.”

Matthew Clark, Ph.D.

Team Leader, Sequencing Technology Development

The Genome Analysis Centre (TGAC), Norwich, UK

OpGen’s Whole Genome Mapping identifies misassemblies and provides the highest quality de novo assembly for further research.

Matthew Clark, Ph.D.
Team Leader, Sequencing Technology Development

“We adopted OpGen’s Argus System as the most advanced way of adding Whole Genome Mapping to improve whole genome sequences. We combined Whole Genome Maps with sequence assemblies to correct errors and misassemblies in bacterial genome sequences as part of our program in the Human Microbiome Project. We are now moving the technology into larger genome projects.”


George Weinstock, Ph.D.

Associate Director
 The Genome Institute at Washington University

We combined Whole Genome Maps with sequence assemblies to correct errors and misassemblies in bacterial genome sequences. This is part of our program from the Human Microbiome Project.

George Weinstock Ph.D.

Associate Director

The Genome Institute at Washington University

“Certain things you just have a tough time answering with de novo sequencing. And assembly doesn’t always work out as sweetly as you would like. So definitely for any whole genome de novo project that people are insistent on closing we would do a Whole Genome Map optically as well as de novo assembly. And the amount of money you would save is in the thousands of dollars in finishing.”

Stefan Green

Director of DNA Services

University of Illinois Chicago Research Resources Center (UIC RRC)

Definitely for any whole genome de novo project that people are insistent on closing we would do a Whole Genome Map.

Stefan Green
Director of DNA Services

CLOSE